Hosted on MSN11d
Study Finds Exenatide Not Beneficial for Parkinson Disease
FRIDAY, Feb. 7, 2025 (HealthDay News) -- The glucagon-like peptide-1 receptor agonist exenatide ... assigned to receive ...
pharmaphorum6d
FDA knocks back Zealand's dasiglucagon once again
Another drugs that may be used off-label for GHI include Xeris' Gvoke brand of glucagon in pre-filled syringe and pen injector formulations, which was approved in 2019 as a hypoglycaemia rescue ...
pharmaphorum6d
CHMP backs Lilly’s Baqsimi as non-injectable for severe low blood sugar
In the US, Baqsimi is now competing head-to-head with Xeris’ Gvoke, pre-filled syringe and pen injector formulations of glucagon that don’t require the mixing steps and can be used in patients ...
cambridgeindependent7d
Arecor lets Tetris go as revenue rises
A full-year 2024 trading update for Arecor Therapeutics shows revenue was up to £5.1million (2023: £4.6m) while cash and cash ...